UBA7

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, UBA7 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated UBA7 data layer compared with 28 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher UBA7 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated UBA7 expression acts as an unfavorable survival marker.

COAD, LSCC, and CCRCC are the cancer types where UBA7 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
COADDFSMedianAll0.9111.000.006102view →
LSCCOSTertileII,III,IV0.5110.882.01013view →
CCRCCDFSTertileIV0.1620.887.03812view →
GBMDFSMedianAll0.2840.458.0174view →
Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

UBA7–COAD (DFS)

Kaplan–Meier survival curve for UBA7 mass-spec protein-high vs -low samples in COAD.

Open the COAD breakdown →

Exploration